Solesence Q4 revenue flat, full-year up 19%

Solesence

31/03/2026 13:10

Overview

US health care solutions provider's Q4 revenue was flat yr/yr, full-year revenue up 19%

Company's Q4 net income turned positive, but full-year net income declined sharply

Company launched Transform & Transcend initiative and expanded patent portfolio in 2025

Outlook

Company expects to deliver on full-year 2026 objectives, citing strong momentum entering the year

Company says Transform & Transcend initiative aims for sustainable, profitable growth above industry averages

Company plans to launch new skin health and healing technology in 2026

Result Drivers

OPERATIONAL INITIATIVES - Co cited the launch of the Transform & Transcend initiative, focused on operational excellence and aligning execution with recent growth, as supporting Q4 momentum

ORGANIZATIONAL CHANGES - Co said organizational changes contributed to strong momentum exiting 2025, per CFO Laura Riffner

NEW BRAND PARTNERS - Co acquired 20 new brand partners in facial skincare and color cosmetics during 2025

Company press release: ID:nGNX8kJGZ3

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
$12.50 mln
Q4 Net Income
$163,000
Q4 Gross Profit
$3.43 mln
Q4 Income From Operations
$186,000


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)